Published in Medical Letter on the CDC and FDA, December 23rd, 2001
TB is the leading killer of AIDS patients, especially in hardest-hit Africa and Asia and over 12 million people are with both diseases among the 40 million living with HIV infection. Since effective treatment of TB in immunocompromised patients has been shown to extend their lives, improved TB drugs that simplify access...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA